Germline Genetic Variation of ASXL1 and BIM Predicts Response to Imatinib and Identifies a Subset of High Sokal Risk Patients with the Greatest Risk of Treatment Failure and Disease Progression

Justine E Marum, Leanne Purins, David T Yeung, Wendy Tara Parker, David J Price, Paul PS Wang, Doris Stangl, Jasmina Geogievski, Bradley Chereda, Andreas Schreiber, Simon J Tuke, Timothy P Hughes, Susan Branford

Blood | AMER SOC HEMATOLOGY | Published : 2015